The Direct and Indirect Costs among U.S. Privately Insured Employees with Hypogonadism

Abstract

Employees with HG had higher comorbidity rates and costs compared with controls. Given the low HG-related costs, a primary driver of costs among HG patients appears to be their comorbidity burden.